282
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Dysthymia and double depression

Pages 3-8 | Published online: 11 Jul 2009

References

  • Akiskal, H. S. (1983). Dysthymic disorder: Psychopathology of proposed chronic depressive subtypes. American Journal of Psychiatry, 140, 11–20.
  • Akiskal, H. S., Rosenthal, T. L., Haykal, R F., Lemmi, H., Rosenthal, R. H. & Scott-Strauss, A. (1980). Characterological depressions: Clinical and sleep EEG findings separating `subaffective dysthymias' from 'character spectrum disorders.' Archives of General Psychiatry, 37, 777–783.
  • American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders (Third Edition). Washington, DC: American Psychiatric Association.
  • American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition). Washington, DC: American Psychiatric Association.
  • Devanand, D. P., Nobler, M. S., Singer, T., Kiersky, J. E., Turret, N., Roose, S. P., et al. (1994). Is dysthymia a different disorder in the elderly? American Journal of Psychiatry, 46, 1592–1599.
  • Dunner, D. L. (1996a). Efficacy of selective serotonin re-uptake inhibitors in the treatment of dysthymia. In: J. P. Feighner, SE W. F. Boyer (Eds.), Selective serotonin re-uptake inhibitors: Advances in basic research and clinical practice (Second Edition) (pp. 223–232). Chichester: John Wiley & Sons.
  • Dunner, D. L. (1996b). Classification and assessment of mood and anxiety disorders. Current Review of Mood and Anxiety Disorders, 1, 1–11.
  • Dunner, D. L. (1998). Treatment of dysthymic disorder. Depression and Anxiety, 8 (Suppl. 1), 54–58.
  • Dunner, D. L. (1999). Duration of euthymia in dysthymic patients. American Journal of Psychiatry, 156, 1992–1993.
  • Dunner, D. L. (2001). Acute and maintenance treatment of chronic depression. Journal of Clinical Psychiatry, 62 (Suppl. 6), 10–16.
  • Dunner, D. L. (2003). Current therapeutic approaches for dysthymic disorder. Expert Review of Neurotherapeutics, 3, 119–125.
  • Dunner, D. L., Hendrickson, H. E., Bea, C., & Budech, C. B. (1997). Venlafaxine in dysthymic disorder. Journal of Clinical Psychiatry, 58, 528–531.
  • Dunner, D. L., Hendrickson, H. E., Bea, C., Budech, C. B., & Friedman, S. D. (2002). Dysthymic disorder: Treatment with citalopram. Depression and Anxiety, 51, 18–22.
  • Dunner, D. L., Hendrickson, H. E., Bea, C., Budech, C. B., & O'Connor, E. (1999). Dysthymic disorder: Treatment with mirtazapine. Depression and Anxiety, 10, 68–72.
  • Dunner, D. L., Schmaling, K. B., Hendrickson, H., Becker, J., Lehman, A., & Bea, C. (1996). Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder. Depression, 4, 34–41.
  • Friedman, R. A., Markowitz, J. C., Parides, M., & Kocsis, J. H. (1995). Acute response of social functioning in dysthymic patients with desiplamine. Journal of Affective Disorders, 34, 85–88.
  • Gabbard, G. 0. (1994). 'Affective disorders' in Psychodynamic Psychiatry in Clinical Practice (pp. 219–248). Washington, DC: American Psychiatric Association: 8.
  • Gelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., et al. (2003). Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biological Psychiatry, 54, 806–817.
  • Han L., Schmaling, K. B., SE Dunner, D. L. (1995). Descriptive validity and stability of diagnostic criteria for dysthymic disorder. Comprehensive Psychiatry, 36, 338–343.
  • Hirschfeld, R. M. A. (1994). Major depression, dysthymia and depressive personality disorder. British Journal of Psychiatry, (Suppl. 26), 23–30.
  • Howland, R. H. (1991). Pharmacotherapy of dysthymia: A review. Journal of Clinical Psychopharmacology, 11, 83–92.
  • Howland, R. H. (1993). Chronic depression. Hospital and Community Psychiatry, 44, 633–639.
  • Keller, M. B., SE Shapiro, R. W. (1982). Double depression: Superimposition of acute depressive episodes on chronic depressive disorders. American Journal of Psychiatry, 139, 438–442.
  • Keller, M. B., Gelenberg, A. J., Hirschfeld, R M. A., Rush, A. J., Thase, M. E., Kocsis, J. H., et al. (1998a). The treatment of chronic depression: A double-blind, randomized trial of sertraline and imipramine. Journal of Clinical Psychiatry, 59, 598–607.
  • Keller, M. B., Klein, D. N., Hirschfeld, R. M. A., Kocsis, J. H., McCullough, J. P., Miller, I., et al. (1995). Results of the DSM-IV mood disorders field trial. American Journal of Psychiatry, 152, 843–849.
  • Keller, M. B., Kocsis, J. H., Thase, M. E., Gelenberg, A. J., Rush, A. J., Koran, L., et al. (1998b). Maintenance phase efficacy of sertraline for chronic depression: A randomized trial. Journal of the American Medical Association, 280, 1165–1672.
  • Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., et al. (2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462–1470.
  • Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshelman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
  • Klein, D. N., Norden, K. A., Ferro, T., Leader, J. B., Kasch, K. L., Klein, L. M., et al. (1998). Thirty-month naturalistic follow-up study of early-onset dysthymic disorder: Course, diagnostic stability, and prediction of outcome. Journal of Abnormal Psychology, 107, 338–348.
  • Klein, D. N., Riso, L. P., Donaldson, S. K., Schwartz, J. E., Anderson, J. L., Ouimette, P. C., et al. (1995). Family study of early-onset dysthymia. Archives of General Psychiatry, 52, 487–496.
  • Klein, D. N., Schwartz, J. E., Rose, S., & Leader, J. B. (2000). Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study. American Journal of Psychiatry, 157, 931–939.
  • Kocsis, J. H., Friedman, R. A., Markowitz, J. C., Leon, D. C., Miller, N. L., Gniwesch, L., et al. (1996). Maintenance therapy for chronic depression: A controlled trial of desipramine. Archives of General Psychiatry, 53, 769–776.
  • Kocsis, J. H., Frances, A. J., Voss, C. B., Mann, J. J., Mason, B. J., & Sweeney, J. (1988). Imiprarnine treatment for chronic depression. Archives of General Psychiatry, 45, 253–257.
  • Kovacs, M., Akiskal, H. S., Gatsonis, C., & Parrone, P. L. (1994). Childhood-onset dysthymic disorder: Clinical features and prospective naturalistic outcome. Archives of General Psychiatry, 51, 365–374.
  • Lyons, M. J., Eisen, S. A., Goldberg, J., True, W., Lin, N., Meyer, J. M., et al. (1998). A registry-based twin study of depression in men. Archives of General Psychiatry, 55, 468–472.
  • Markowitz, J. C. (1994). Psychotherapy of dysthymia. American Journal of Psychiatry, 151, 1114–1121.
  • Markowitz, J. C. (1996). Psychotherapy for dysthymic disorder. Psychiatric Clinics of North America, 19, 133–149.
  • McCollough, J. P. (2000). Treatment for chronic depression: Cognitive behavioral analysis system of psychotherapy. New York, Guilford Press.
  • McCullough, J. P. (1991). Psychotherapy for dysthymia: A naturalistic study of ten patients. Journal of Nervous and Mental Disease, 179, 734–740.
  • Pages, K. P., & Dunner, D. L. (1997). Focus on dysthymic disorder and chronic depression. In: D. L. Dunner, SE J. F. Rosenbaum (Eds.), The Psychiatric Clinks of North America Annual of Drug Therapy (pp. 91–109). Philadelphia: W.B. Saunders Co.
  • Ravindran, A. V., Anisman, H., Merali, Z., Charbonneau, Y., Telner, J., Bialik, R. J., et al. (1999). Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments. American Journal of Psychiatry, 156, 1608–1617.
  • Ravindran, A. V., Bialik, R. J., SE Lapierre, Y. D. (1994). Therapeutic efficacy of specific serotonin re-uptake inhibitors (SSRI's) in dysthymia. Canadian Journal of Psychiatry, 39,21–26.
  • Shores, M. M., Glubin, T., Cowley, D. S., Dager, S. R, Roy-Byrne, P. P., SE Dunner, D. L. (1992). The relationship between anxiety and depression: A clinical comparison of generalized anxiety disorder, dysthymic disorder, panic dis-order, and major depressive disorder. Comprehensive Psychiatry, 33,237–244.
  • Thase, M. E., Fava, M., Halbreich, U., Koran, L., Davidson, J., Rosenbaum, J., et al. (1996). A placebo-controlled, randomized clinical trial comparing sertraline and imiprarnine for the treatment of dysthymia. Archives of General Psychiatry, 53, 777–784.
  • Weissman, M. M., SE Klerman, G. L. (1977). The chronic depressive in the community: Unrecognized and poorly treated. Comprehensive Psychiatry, 18, 523–532.
  • Weissman, M. M., Leaf, P. J., Bruce, M. L., SE Florio, L. (1988). The epidemiology of dysthymia in five communities: Rates, risks, comorbidity and treatment. American Journal of Psychiatry, 145, 815–819.
  • Yang, T., 8z Dunner, D. L. (2001). Differential subtyping of depression. Depression and Anxiety, 13, 11–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.